{
    "nctId": "NCT04611620",
    "briefTitle": "Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms",
    "officialTitle": "Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms",
    "overallStatus": "COMPLETED",
    "conditions": "Survivorship, Cognitive Dysfunction, Pain, Depression, Anxiety, Fatigue, Sleep Disturbance",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 682,
    "primaryOutcomeMeasure": "Subjective Cognitive Dysfunction",
    "eligibilityCriteria": "Inclusion Criteria:\n\nInclusion Criteria for Breast cancer survivors:\n\n1. Female BCS\n2. \u2265 21 years of age and older\n3. Ability to provide written consent and HIPAA authorization\n4. \u22656 months post-adjuvant therapy and neo-adjuvant therapy for early stage (Stage I-IIIA) breast cancer.\n\n   Current Aromatase Inhibitors or Tamoxifen treatment at time of enrollment is allowed.\n5. Identify cognitive concerns (select yes)\n\nInclusion Criteria for Colorectal cancer survivors:\n\n1. Male or female CRC survivors\n2. Ability to provide written consent and HIPAA authorization\n3. \u2265 21 years of age and older\n4. \u22656 months post-adjuvant therapy and neo-adjuvant therapy for early stage (stage I-III) CRC\n5. Identify cognitive concerns (select yes)\n\nExclusion Criteria:\n\n1. Report metastatic breast or colorectal cancer (Stage IV) at time of consenting.\n2. Unable to read and understand English to complete survey questionnaires.",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}